G. Greim

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin

M. Borner, Patrick Schöffski, Ronald de Wit et al. · European Journal of Cancer · 2002 · 319 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

Ch. Dittrich, G. Greim, Markus Borner et al. · European Journal of Cancer · 2002 · 71 citations

Medicine, Pharmacokinetics, Pharmacology +8

Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule

Cristiana Sessa, K. Weigang-Köhler, Olivia Pagani et al. · European Journal of Cancer · 2002 · 69 citations

Medicine, Pharmacokinetics, Pharmacology +9

Activity of the dolastatin analogue, LU103793, in malignant melanoma

John Smyth, M.E. Boneterre, Jan H.M. Schellens et al. · Annals of Oncology · 2001 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.

Ferry A.L.M. Eskens, G. Greim, C. van Zuylen et al. · PubMed · 2000 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17